	Irisin and endocrine-metabolic indicators as predictors of IVF-ET pregnancy outcomes in Chinese women with PCOS. Front Endocrinol (Lausanne) Wang H, Su C, Jin W, Lu W, Bi T, Cheng Q, Ji D. PMID: 42666139 [PubMed - indexed for MEDLINE]
	Targeted therapy plus chemotherapy for advanced or metastatic triple-negative breast cancer: a PRISMA 2020 systematic review and meta-analysis. Front Oncol Li Y, Li Z, Shi X, Zuo H. PMID: 42666138 [PubMed]
	Dementias in Older Women With Early-Stage HER2-Negative Breast Cancer Treated With Anthracycline Plus Taxane Versus Taxane-Based Chemotherapy Regimens. Pharmacoepidemiol Drug Saf Le N, Anne N, Shen C, Pallapothu R, Liu Y, Park C. PMID: 42665946 [PubMed - indexed for MEDLINE]
	Integrated multi-omics, machine learning, network toxicology, and molecular docking reveal potential mechanisms underlying methyl 4-hydroxybenzoate-associated breast cancer. Mol Divers Li C, Zeng X, Mao Y. PMID: 42665765 [PubMed - as supplied by publisher]
	Herpetic reactivation during radiotherapy treatment for gynaecological cancers-a retrospective observational study. Support Care Cancer Tom DC, Udayashankara AH, S N, F HNA, R J, Garg S, Raj JM. PMID: 42665708 [PubMed - indexed for MEDLINE]
	Total moderate-to-vigorous physical activity across the adult life course and the risk of invasive ovarian cancer. Int J Epidemiol Ritonja JA, Madathil S, Nicolau B, Leung L, Ho V, Abrahamowicz M, Koushik A. PMID: 42665563 [PubMed - indexed for MEDLINE]
	High-density lipoprotein-related inflammatory indices and gynaecological cancer history: a cross-sectional analysis of NHANES. J Obstet Gynaecol Yang X, Cheng S, Wei S, Liu X, Zhao W, Chu Y, Huo Y. PMID: 42665432 [PubMed - indexed for MEDLINE]
	Successful Management of Ultra-high-risk Mixed Ovarian Germ Cell Tumor Using a Pediatric-inspired Intensive Chemotherapy Regimen: A Case Report. In Vivo Lee J, Lee HJ, Song SH, Park SY, Kim DJ, Lee IH, Park M, Lim MC, Park SY, Kim JH. PMID: 42665409 [PubMed - indexed for MEDLINE]
	Combined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy. In Vivo Ying M, Fan Z, He Y, Qi M, Dong B, Lu A, Li J, Xie Y, Wang T, Lin B, Ouyang T. PMID: 42665378 [PubMed - indexed for MEDLINE]
	French multicentre randomised phase III trial evaluating the efficacy and safety of vaginal radiofrequency in the management of vulvovaginal atrophy and dryness in patients treated for breast cancer (RF-Vaginale): trial protocol. BMJ Open Demetz J, Vanseymortier M, Martin C, Ben Oune F, Alloy N, Leguillette C, Penel N, Chauvet MP, Le Deley MC. PMID: 42665344 [PubMed - indexed for MEDLINE]
	Role of estrogen receptor α in the regulation of breast cancer progression: signaling pathways and therapeutic implications. Gene Samuel BA, Jubie S, Jawahar N, Namboori PK, Philip AK. PMID: 42665030 [PubMed - as supplied by publisher]
	Development and validation of a serum peptidomic signature for early detection of asymptomatic ovarian cancer: A multi-center prospective study. Cell Rep Med Li Z, Zhang H, Bi R, Zhang Y, Shi W, Yang H, Cheng S, Wang C, Zhao Y, Li Y, Lu X, Chen X, Zhou Y, Dong B, Xue R, Wang Y. PMID: 42664958 [PubMed - as supplied by publisher]
	Artificial intelligence in population breast cancer screening: A two-year cost-effectiveness analysis. Soc Sci Med Scarfe J, Marinovich ML, Houssami N, Pearce A. PMID: 42664747 [PubMed - as supplied by publisher]
	Leveraging artificial intelligence in the early detection of ovarian cancer: Development and validation of a risk prediction model. Gynecol Oncol Chapman GC, Fedorenko O, Sheyn D, Reid A, Taylor L, Ray S, Lynam SK. PMID: 42664614 [PubMed - as supplied by publisher]
	Cognitive profiles and predictors of cancer-related cognitive impairment in breast cancer survivors: integrating self-reported, neuropsychological, and process-based measures. Arch Clin Neuropsychol Salgado-Blanco C, Blanco-Campal A, Diaz-Orueta U. PMID: 42664413 [PubMed - indexed for MEDLINE]
	Monitoring ovarian reserve dynamics via a high-sensitivity anti-Müllerian hormone assay in premenopausal breast cancer patients undergoing chemotherapy. Hum Reprod Kuang X, Ji M, Tang Y, Wang Q, Pan S, He J, Anderson RA, Wang BS, Xu H, Lai D. PMID: 42664366 [PubMed - as supplied by publisher]
	Genotype distribution of high-risk and potential high-risk HPV types among women in different screening and clinic settings in Ghana and Kenya. PLoS One Kwesi-Maliepaard EM, Osea-Larbi JA, Nyamari CK, Alhassan Y, Sromani AK, Kotey VM, Darko S, Tackie R, Kiome R, Mohammed AM, Buadii E, Quaye EK, Akligoh H, Ibrahim BA, Kaba P, Amoako SF, Kotey E, Agyemang S, Ngoi JM, Paemka L, Darkwa K, Degley T, Siebu NE, Olwal CO, Morang'a CM, Manu A, Hutchful D, Amoako E, Onyambu FG, Bediako Y. PMID: 42664253 [PubMed - indexed for MEDLINE]
	An interpretable Hallmark pathway activity classifier for distinguishing CIN3/HSIL from invasive cervical squamous carcinoma: Development, external validation, and feature stability assessment. PLoS One Jia M, Song Y, Shang J, Zhuang L, Xie S, Cao N, Ye S, Zhuo Y, Ye M. PMID: 42664194 [PubMed - indexed for MEDLINE]
	Comparative study between contrast enhanced mammography and breast MRI in local pre-operative staging of invasive lobular carcinoma: A cross-sectional study. Clin Ter Georgy MSN, Abdallah RH, Othman AG, Naeim RM, Keriakos NNH. PMID: 42664142 [PubMed - indexed for MEDLINE]
	Imaging the invisibility: Predicting histopathology through mammographic clues in invasive breast cancer. Clin Ter Prakash K P, Athiyamaan MS, Banerjee S, Krishna A, Sunny J, Simon P, Rai S, Srinivas C, Lobo D. PMID: 42664124 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 334377

Page 1 of 16719



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy